Companies: 10,795·Total market cap: $144.5T
CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

CAMPNASDAQHealthcare● Active
$4.09
$-0.02(-0.49%)
Market Cap$86872512
P/E Ratio
52W High$7.75
52W Low$1.305
Overview

CAMP4 Therapeutics Corporation (CAMP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CAMP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.27camp eps ttm · camp earnings per shareEarnings history
PE Ratio (TTM)camp pe ratio ttm · camp price to earningsPE Ratio deep dive
Revenue (TTM)$3.9Mcamp revenue ttm · camp annual revenueFull revenue history
Dividend YieldNo Dividenddoes camp pay dividends · camp dividend yieldDividend history
Shares Outstanding30.4Mcamp shares outstanding · camp floatShares outstanding history
Next EarningsAug 13, 2026Est.camp earnings date · camp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.5M▲ +436.50% YoY
202320242025
camp4 therapeutics corporation revenue · camp revenue 2025
FY 2025Net Income-$80.4M▼ 55.25% YoY
202320242025
camp4 therapeutics corporation net income · camp profit 2025
FY 2025EPS$-2.65▲ +0.38% YoY
202320242025
camp eps · camp4 therapeutics corporation earnings per share 2025
TTM:Revenue: $3.9MNet Income: -$86.3MEPS: $-2.27View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy24 analystsis camp a buy · camp analyst rating
Strong Buy
0
Buy
16
Hold
7
Sell
1
Strong Sell
0
12-Month Price Target
$5.00Low
$4.09Current
$11.40Avg Target178.73% upside
$18.00High
camp price target · camp 12 month forecast

Total: 24 · Buy rate: 66.7%

The CAMP analyst consensus is Buy, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month price target is $11.40, representing +178.73% upside from the current price of $4.09.

Stock Performance

Full History
1D-0.49%
1W+2.76%
1M-8.30%
3M-2.62%
YTD-33.28%
1Y+124.73%
5Y-61.85%

About CAMP4 Therapeutics Corporation

CEOJoshua Mandel-Brehm
IPO DateOct 11, 2024
Employees55
CountryUS

CAMP4 Therapeutics Corporation a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and developme…

what is camp4 therapeutics corporation · camp stock overview · camp4 therapeutics corporation company profile · who is camp4 therapeutics corporation ceo · camp NASDAQ · camp4 therapeutics corporation headquarters · camp4 therapeutics corporation business segments

About Stock Overview & Key Data

CAMP4 Therapeutics Corporation (CAMP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2024. As of the latest trading session, CAMP stock price is $4.09, with a market capitalization of $86.9M. The stock has returned +124.73% over the past 12 months and -33.28% year-to-date.

According to 24 Wall Street analysts, the consensus rating for CAMP4 Therapeutics Corporation stock is Buy, with an average 12-month price target of $11.40. In fiscal year 2025, CAMP4 Therapeutics Corporation reported revenue of $3.5M and net income of -$80.4M. For detailed data — including CAMP4 Therapeutics Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CAMP4 Therapeutics Corporation (CAMP) stock price is $4.09. The stock is traded on NASDAQ under the ticker symbol CAMP. The 52-week range is $1.30 – $7.75.

CAMP stock priceCAMP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice